Impact

We are in the early stages of the study but we are already seeing pathways to impact through our work with different collaborators including: working with the World Health Organisation (WHO); the World Federation of Neurology (WFN); the Academy of Medical Sciences and the Global NeuroCOVID Coalition.

COVID-19 encephalopathy guidance

Dr Benedict Michael co-Chairs the Global NeuroCOVID Coalition Task Force on Acute Clinical Care for Neurological complications of COVID-19. The task force has compiled clinical guidelines for the management of COVID-19 Encephalopathy. This has been a global collaboration to gain consensus on how to treat this neurological complication.

WHO COVID-neuro clinical exchange

Dr Benedict Michael also sits on the WHO Expert Forum on Neurology and COVID-19. Together with the Global Health Network and the Global NeuroCOVID Coalition he co-organises the COVID-Neuro Clinical Exchange Platform. Dr Michael chairs this clinical exchange alongside the Global Health Network. Dr Michael and Dr Greta Wood have coordinated a monthly interchange with clinicians located all over the world to share experiences faced during the COVID-19 pandemic. The goal is to promote discussion around neurological care and COVID-19 in all settings, with themes such as clinical challenges, essential services, workforce and diagnostics.

Brain Health Clinical Exchange

The Brain Health Clinical Exchange is co-organised by the World Health Organisation (WHO) Neurology & COVID-19 Global Forum and The Global Health Network.

The first Brain Health Clinical Exchange was held on 30 November 2021 on the topic: Seizures in the Fields…Using Public Health to Address Neurologic Illness..

In this interactive workshop, Dr James Sejvar, from the U.S. Centers for Disease Control and Prevention (CDC), used a recent outbreak investigation to outline how public health professionals go about solving medical mysteries.

Inter-observer variability study

The WHO and the WFN are supporting a global inter-observer variability study of the COVID-CNS n-Case Record Form, that the COVID-CNS team use to record all in-patient data, as part of their inter-observer variability study being conducted across 14 countries worldwide, in high, middle and low income settings.

WHO expert workshop on encephalitis

Dr Ava Easton, CEO of the Encephalitis Society and Chair of the COVID-CNS PPI panel, and Dr Michael are working with the WHO to support expert workshops to develop global policy, looking at implementation and setting a research agenda on encephalitis, with greater emphasis on lower and middle income countries (LMICs). This workshop addresses policymakers, service providers, academics, researchers and civil society representatives. For more information, see media and news.

Panels

Dr Michael sits on the advisory panel for the Academy of Medical Sciences and the National Institute for Health and Care Excellence (NICE) with regards to research and management of neurological complications of COVID-19 respectively. He also forms part of the WHO expert panel on COVID-19 neurology, as part of the WHO’s Brain Health Unit.

WHO scientific brief on neurology and COVID-19

As members of the WHO Neurology and COVID-19 Global Forum Dr Michael, Professor Solomon and Dr Wood have contributed to the WHO's Scientific Brief on Neurology and COVID-19. The Scientific Brief gives an overview of what is currently known about the acute neurological manifestations of COVID-19; the neurological symptoms associated with post-COVID-19 condition; the risk of infection, severe illness and mortality from COVID-19 for people with pre-existing neurological conditions; as well as the emerging evidence for neurological complications following COVID-19 vaccination. 

Back to: COVID-19 Clinical Neuroscience Study (COVID-CNS)